M.A. Christine Pratt

Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.

Christine Teixeira, John C. Reed, M.A. Christine Pratt · PubMed · 1995 · 421 citations

Breast Oncology, Chemoprevention Strategy, Cell Death +19

A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell.

M.A. Christine Pratt, Jarmila Králová, Michael W. McBurney · Molecular and Cellular Biology · 1990 · 131 citations · Full text

Mutant Gene, P19 Cells, Developmental Biology +13

Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage

A. C. SAU, Rosanna Lau, Miguel A. Cabrita et al. · Cell stem cell · 2016 · 113 citations · Full text

Genome Instability, Dna Damage, Cell Regulation +13

Estrogen Withdrawal-Induced NF-κB Activity and Bcl-3 Expression in Breast Cancer Cells: Roles in Growth and Hormone Independence

M.A. Christine Pratt, Tanya E. Bishop, Dawn White et al. · Molecular and Cellular Biology · 2003 · 107 citations · Full text

Breast Oncology, Hormone Independence, Gynecology +18

CDK2 Is a Target for Retinoic Acid-Mediated Growth Inhibition in MCF-7 Human Breast Cancer Cells

Christine Teixeira, M.A. Christine Pratt · Molecular Endocrinology · 1997 · 90 citations · Full text